The federal government has moved to block Samhsa funding from paying for fentanyl test strips and other drug-checking kits, and health experts say the decision could cost lives.
An open letter issued in April by the Substance Abuse and Mental Health Services Administration ordered grant recipients to stop using its funds to buy or distribute substance testing strips, including those used to detect fentanyl, xylazine and medetomidine. Officials described the move as a clear break from harm reduction, according to reports, marking a sharp change in how the administration wants federally supported drug policy to operate.
Key Facts
- Samhsa said its funding cannot be used to purchase or distribute fentanyl test strips or other drug test kits.
- The restriction extends beyond fentanyl to strips for xylazine and medetomidine.
- Experts and critics warn the policy change could increase overdose risk.
- The administration has framed the move as a shift away from harm reduction.
That matters because test strips often serve as a low-cost, fast way for people to check whether drugs contain dangerous substances. Public health advocates have long argued that these tools help people make safer decisions in a market increasingly contaminated by potent synthetic drugs and sedatives. Cutting off federal support does not ban the strips outright, but it threatens access for programs that rely on government grants to reach people at highest risk.
Experts warn that pulling federal support from drug-checking tools removes one of the simplest barriers between a contaminated supply and a fatal overdose.
The decision also lands as the street drug supply keeps shifting. Reports indicate xylazine and medetomidine have deepened fears among clinicians and outreach workers, who already face an overdose crisis shaped by rapid changes in what people actually consume. Critics argue that reducing support for testing tools ignores that reality and weakens programs built around practical, immediate risk reduction rather than abstinence-only messaging.
What happens next will likely play out at the local level, where health departments, nonprofits and community groups must decide whether they can replace the lost funding with state, private or emergency support. The stakes reach beyond one budget line: this move signals how the administration may approach addiction policy more broadly, and communities on the front lines will now have to absorb the risk.